The Symposium - Research papers

Mar 26, 2026 PLoS Pathogens

New Antibody Shows Promise Against SARS-CoV-2

Scientists have discovered a new antibody that can effectively neutralize the SARS-CoV-2 virus, which causes COVID-19, and it works in a unique way. The antibody, called IgM-14, is able to target and block the virus in a way that other antibodies can't, and it's particularly effective against older variants of the virus. However, it loses its effectiveness against newer variants, such as Omicron BA.1 and JN.1. Researchers found that these newer variants have mutations that disrupt the antibody's ability to bind to the virus, and that the antibody can only work if it binds to two specific parts of the virus. This discovery could lead to the development of new and more effective antibody treatments for COVID-19.

View Source Share

Mar 20, 2026 PLoS Pathogens

New Breakthrough in COVID-19 Research

New research has found that a protein called SAMHD1 plays a crucial role in preventing the SARS-CoV-2 virus from infecting lung cells. The study discovered that when SAMHD1 is removed from lung cells, the virus is unable to enter the cells and replicate. This happens because SAMHD1 helps to suppress the production of a protein called ACE2, which is necessary for the virus to attach to and enter the cells. Without ACE2, the virus is unable to infect the cells, making SAMHD1 a potential target for developing new treatments for COVID-19.

Source Share

Mar 18, 2026 BMJ Medicine

NHS Primary Care Guidance Gap Exposed

A new study has found that the number of people receiving advice and guidance from their primary care doctor has skyrocketed over the past eight years, increasing by 19 times from 2015 to 2023. During the COVID-19 pandemic, this number doubled, with over 1 in 10 patients receiving advice and guidance. However, the study also revealed significant inequalities in the use of these services, with older, white, and less deprived patients receiving more advice and guidance, while minority ethnic and more deprived groups took longer to recover from the pandemic.

Source Share

Mar 13, 2026 PLoS Pathogens

Unlocking SARS-CoV-2's Deadly Immune Response

Researchers have made a significant discovery about how the immune system fights the COVID-19 virus. They found that a key way the immune system kills infected cells is through a process called antibody-dependent cellular cytotoxicity (ADCC), where antibodies bind to the virus and then trigger the immune cells to destroy it. The study analyzed 142 different antibodies that target the COVID-19 virus and found that the part of the antibody that binds to the virus is the most important factor in determining how well it can trigger ADCC. This new understanding could lead to better vaccine designs and the development of more effective treatments.

Source Share

Mar 12, 2026 PLoS Pathogens

Breakthrough Inhibitor Blocks Multiple Viruses

Scientists have discovered a new medicine that can stop multiple types of viruses that cause serious illnesses in children, including hand, foot, and mouth disease. The medicine, called bofutrelvir, targets a key part of the virus called 3C protease, which is also found in the coronavirus that causes COVID-19. In animal tests, bofutrelvir was shown to be highly effective in reducing the severity of the virus and alleviating symptoms, even when given orally. This is significant because there is currently no vaccine that can protect against all types of enteroviruses, and finding a medicine that can target multiple viruses is a major breakthrough in the fight against these illnesses.

Source Share

Feb 26, 2026 PLoS Pathogens

New Biotherapeutic Offers Hope Against COVID

New research has found that a simple bacteria called Caulobacter crescentus can be used to boost the body's natural defenses against respiratory infections. The scientists tested this idea by giving mice and hamsters different types of viruses and bacteria, including those that cause COVID-19 and influenza. They found that the treated animals had significantly lower levels of infection and were able to fight off the pathogens more effectively. This is a promising discovery because it could lead to new treatments for respiratory infections, which are often difficult to treat with traditional vaccines or medications.

Source Share

Feb 24, 2026 PLoS Pathogens

Breakthrough for COVID-19 Treatment Discovery

Scientists have made a breakthrough in understanding how to combat two viruses that cause severe respiratory illnesses, including COVID-19. By studying the structure of the main enzyme responsible for these viruses' replication, researchers discovered that a specific compound can effectively inhibit the virus's ability to multiply. This is significant because the virus's enzyme has different structures and functions depending on which type of coronavirus it belongs to - one from pigs and another from humans. The discovery could lead to the development of new treatments that are effective against both types of viruses, offering hope for a more comprehensive solution to combat these illnesses.

Source Share

Feb 21, 2026 PLoS Pathogens

Breakthrough Nanoparticles Neutralize SARS-CoV-2 Variants

Researchers have discovered a new way to create a vaccine that can protect against multiple variants of COVID-19. They designed a tiny particle called a nanoparticle that displays a specific part of the virus's spike protein, which is recognized by the immune system as foreign. This nanoparticle was engineered to stimulate an immune response that not only protects against the original strain of the virus but also against many of its variants, including the Omicron variant. The study found that this single component nanoparticle can induce a strong and durable antibody response in both people who have never been infected with COVID-19 and those who have already received vaccinations, offering a promising new approach to combat the rapidly evolving threat of the virus.

Source Share

Feb 21, 2026 PLoS Pathogens

New Antibody Boosts COVID Infection

Researchers have discovered a new type of antibody that helps the COVID-19 virus infect cells, despite being designed to fight it. This antibody, called ConD-854, targets a specific part of the virus's spike protein but works in a way that's different from other antibodies that are meant to neutralize the virus. The scientists found that this antibody can enhance the virus's ability to enter cells, even though it was created by someone who had already been infected with the Delta variant of COVID-19. This discovery could help us better understand how our bodies respond to COVID-19 and potentially lead to new ways to design vaccines or treatments for the disease.

Source Share

Feb 21, 2026 PLoS Pathogens

Breakthrough Discovery Regulates COVID Pneumonia

New research has found that a specific enzyme called Regnase-1 plays a crucial role in how our immune system responds to the COVID-19 virus. The study discovered that mice with reduced levels of this enzyme were more resistant to infection and developed less severe pneumonia, suggesting that Regnase-1 helps regulate the immune response to prevent excessive inflammation. In particular, the researchers found that neutrophils, a type of white blood cell, were affected by the lack of Regnase-1, leading to an overactive response that could exacerbate the disease.

Source Share

Explore Original Research

Want to dive deeper? These journals publish the original peer-reviewed research we summarize:

Nature Science The Lancet NEJM BMJ Cell JAMA PLOS ONE

Today's Top Research

Explore Original Research